Trial Profile
A Phase II, Randomized Study of T DM1 versus T DM1 plus short induction with docetaxel in first line treatment for locally advanced or metastatic HER2+ breast cancer.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 May 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab emtansine (Primary) ; Docetaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 30 Oct 2014 New trial record